Dr Simonida Bobić

medikalni onkolog

Obrazovanje:

2010 Osnovne studije, Medicinski fakultet Univerziteta u Beogradu,
2023 Specijalizacija, Internistička onkologija, Medicinski fakultet Univerziteta u Beogradu
2017 Započete doktorske studije iz Biologije tumora, Medicinski fakultet Univerziteta u Beogradu
2023 ESMO (Evropsko drustvo medikalnih onkologa) ispit

Radno iskustvo:

Od 2010 Institut za onkologiju i radiologiju Srbije, Klinika za medikalnu onkologiju, Odeljenje za bolesti karcinoma dojke i ginekologije

Klinička ispitivanja:

Različita randomizovana multicentrična međunarodna klinička ispitivanja faze III

Stručno usavršavanje:

May 2007. 30.International medical scientific congress for students and young doctors, Ohrid, Macedonia
Feb 2009. International congress of endocriniologists and cardiologists, Vrsac, Serbia
May 2011. 5th Conference of Serbian Society of Medical Oncology (UMOS) – Geriatric oncology –challenges and dilemmas, Kladovo, Serbia
May 2012. 2nd Balkan Masterclass in Clinical Oncology, Dubrovnik, Croatia
September 2012. Best of ASCO, Belgrade, Serbia
April 2013. Oncology A seminar :Breast and Gynecologic Cancers, Salsburg, Austria
October 2013. 7th Conference of Serbian Society of Medical Oncology, Belgrade, Serbia ·
27.06.-02.07.2014.: ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Brdo Slovenia
28. – 29.10.2015. ESO masterclass in clinical oncology, Tblisi, Georgia
02.-03.02.2017. ESMO Preceptorship in Immuno-Oncology, Madrid, Spain
Dobitnik 2017. Conquer Cancer Foundation International Development and Educational Award (IDEA) pod mentorstvom prof.Rugo Hope (UCSF)
02.-06.06.2017. – 2017.ASCO Annual Meeting
10-11.11.2017. ESMO Preceptorship Breast Cancer, Lisbon, Portugal
12.07.2018. – 15.07.2018. Baltic and Eurasia Masterclass in Clinical Oncology, Riga, Latvia
06.10.2018 – 08.10.2018. 4th ESO-ESMO Breast Cancer in Young Women International Conference (BCY4), Lugano, Switzerland
16.-17.11.2018. Biosimilars in Cancer Care: Challenges and opportunities for Health Professionals and Patients, Barcelona, Spain
19.08.-21.08.2022. ESMO Academy 2022, Dublin, Ireland
23.10.-24.10.2022. ESMO preceptorship on ovarian cancer 2022, Lisbon
09.06.-10.06.2023. ESMO Advanced Course on Precision Oncology in Breast Cancer 2023., Barcelona, Spain
11.-12.07.2024. ESMO Preceptorship on Uterine Cancer, Lugano, Switzerland
24.03.-25.03.2025. EMEAC Breast Cancer COP, MD Anderson Cancer Center Madrid, Spain.
30.05.-03.06.2025. ASCO Annual Meeting, Chicago, USA
15.-17.05.2025. REKONIO 2025. Budva, Montenegro – predavač po pozivu
14.06.2025. UMOS breast cancer school, Belgrade, Serbia – predavač po pozivu

Publikacije:

· Stamatović Ljiljana, Vasović S., Milović-Kovačević M., Karaferić A., Lukić V., Pupovac S. Tolerability of bevacizumab in metastatic triple-negative breast cancer (TNBC) patients: a single institution experience. BREAST, (2013), vol. 22 (Suppl. 3 ) br. , str. S50-S50 0.5

· A.Karaferić, Milović-Kovačević Marijana, Lj. Stamatović, S.Vasović, S.Pupovac, L.Pavlović. Specifičnosti karcinoma grlića materice u žena mlađe životne dobi . Kancerološka nedelja (51; 2014; Beograd). Program i zbornik radova/ 51.Kancerološka nedelja i 28. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 27-28.novembar 2014.godine). Srpsko lekarsko društvo; Kancerološka sekcija ISSN 2406-0569

· Milović-Kovačević Marijana, Lj. Stamatović, S.Vasović, A.Karaferić S.Pupovac, L.Pavlović. Specifičnosti karcinoma jajnika u pacijentkinja mlađe životne dobi . Kancerološka nedelja (51; 2014; Beograd). Program i zbornik radova/ 51.Kancerološka nedelja i 28. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 27-28 .novembar 2014.godine). Srpsko lekarsko društvo; Kancerološka sekcija ISSN 2406-0569

· J. Spasic, N. Stanic, M. Ristic, F. Djordjevic, N. Nikolic, V. Nikolic, S. Pupovac, D.Radosavljevic , Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia, Ann Oncol (2015) 26 (suppl 4): iv82 doi:10.1093 · Susnjar Snezana V, . Djokic, O, Pupovac Simonida , Mladenovic Jasmina, Gavrilovic Dusica , Long term follow up of elderly women diagnosed with breast cancer (Meeting Abstract), BREAST, (2015), vol. 24 br. , str. S75-S75 · Mladenovic Jasmina , Susnjar Snezana V , Pupovac Simonida, Djokic O, Gavrilovic Dusica . Postoperative radiotherapy in elderly patients with breast cancer: does it influence survival? (Meeting Abstract), BREAST, (2015), vol. 24 br. , str. S131-S131 · Posarac Vladan , Jevric Marko, Susnjar Snezana V , Djokic O, Pupovac Simonida, Gavrilovic Dusica . Comparison of breast cancer disease characteristics between female and male elderly patients (Meeting Abstract), BREAST, (2015), vol. 24 br. , str. S72-S72

· Simonida Pupovac1, Olivera Đokić2, Marijana Milović-Kovačević1, Andjela Karaferic1, Ljiljana Stamatovic1, Snezana Susnjar1. Karakteristike zena starije zivotne dobi dijagnostifikovanih u operabilnom stadijumu bolesti carcinoma dojke i lečenih u Institutu za onkologiju i radiologiju Srbije. Kancerološka nedelja (50; 2013; Beograd). Program i zbornik radova/ 50.Kancerološka nedelja i 27. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 28- 30.novembar 2013.godine). Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-049-4;

· Marijana Milović-Kovačević1, Snezana Susnjar1, Ivana Bozovic-Spasojevic, Zora Neskovic-Konstantinovic, Ljiljana Stamatovic1, Andjela Karaferic1, Simonida

Pupovac1, Tijana Vujasinovic, Zaki Aburabi, Dana Jovaniovic, Dusica Gavrilovic. Uticaj HER 2 statusa na lokalizaciju prvog relapsa u mladih steroid-receptor pozitivnih bolesnica sa karcinomom dojke tretiranih adjuvantnom ablacijom jajnika. Kancerološka nedelja (50; 2013; Beograd). Program i zbornik radova/ 50.Kancerološka nedelja i 27. Stručni sastanak medicinskih sestara-tehničara onkoloških institucija Republike Srbije (Beograd, 28- 30.novembar 2013.godine). Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-049-4;

· Marijana Milović-Kovačević1, Simonida Bobic, The prognosis of patients with endometrial cancer is affected by obesity?, 10.1136/ijgc-2022-ESGO.323

· Pavlovic Lidija, Andjela Karaferic, Simonida Bobic, Milana Matovic, Marijana Milovic-Kovacevic, Marija Radovic, Ljiljana Stamatovic. Efikasnost olapariba kao terapije odrzavanja postignutog odgovora na platina baziranu terapiju kod rekurentnog, epitelijalnog, visoko gradusnog,karcinoma jajnika sa prisutnom somatskom i/ili germinativnom BRCA mutacijom: iskustvo centra. Kancerološka nedelja (59; 2022; Beograd). Zbornik apstrakata 59.Kancerološka nedelja i 35. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije. Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-142-2;

· Karaferic Andjela, Matovic Milana, Marijana Milovic-Kovacevic, Lidija Pavlovic, Simonida Bobic, Marija Radovic, Ljiljana Stamatovic. Bezbednosni profil bevacizumaba u lecenju karcinoma jajnika. Kancerološka nedelja (59; 2022; Beograd). Zbornik apstrakata 59.Kancerološka nedelja i 35. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije. Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-142-2;

· Marija Radovic, Lidija Pavlovic, Marijana Milovic-Kovacevic, Andjela Karaferic, Milana Matovic, Simonida Bobic, Ljiljana Stamatovic. Bezbednosni profil leka olaparib kao terapije odrzavanja kod platina-senzitivnog rekurentnog epitelijalnog karcinoma jajnika visokog gradusa sa BRCA 1/2 mutacijom: Iskustvo Instituta za onkologiju i radiologiju Srbije. Zbornik apstrakata 59.Kancerološka nedelja i 35. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije. Srpsko lekarsko društvo; 616-006 (048); ISBN 978-86-6061-142-2;

· M.Milovic-Kovacevic, S.Bobic, A.Karaferic, L.Pavlovic, M. Matovic, B.Poparic-Bandjur. Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2? Breast Cancer at a Single Cancer Center. P082, SGBCC2023.

· Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers. Dragana Miletić, Marija Kraljević, Emir Sokolović, Majana Soč, Marijana Milović-Kovačević, Simonida Bobić, Timur Cerić, Stjepko Pleština, Semir Bešlija, Inga Marijanović. Med Sci Monit 2023; 29:e940356 :: DOI: 10.12659/MSM.940356

· Olaparib as a first-line maintenance treatment for BRCA-positive ovarian cancer patients: single-institution experience. Marijana Milovic-Kovacevic, Lidija Pavlovic, Milana Matovic, Simonida Bobic, Slobodan Kutic, Ljiljana Stamatovic. 4th Regional congress of Medical Oncology, Septembar 2023, Ljubljana, Slovenia, Book of abstracts, p 79-80

· Predicting factors for progression free survival (PFS) in breast cancer patients treated with ribociclib with endocrine therapy (ET). Cosovic Vojislav, Novakovic Teodora, Bobic Simonida, Kutic Slobodan, Mijucic Jovana, Pavlovic Lidija, Karaferic Andjela,

Matovic Milana, Milovic Kovacevic Marijana. Kancerološka nedelja (61; 2024; Beograd). Zbornik apstrakata 61.Kancerološka nedelja i 37. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije.

· Efficacy of trastuzumab emtansine (TDM1) in metastatic breast cancer depending on the duration of response to adjuvant HER2 therapy. Novakovic Teodora, Bobic Simonida, Kutic Slobodan, Mijucic Jovana, Cosovic Vojislav,Milovic Kovacevic Marijana.Kancerološka nedelja (61; 2024; Beograd). Zbornik apstrakata 61.Kancerološka nedelja i 37. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije.

· Granulosa cell tumour: 14 years expeience of a Tertiary Center in Serbia. Kutic S., Karaferic A., Pavlovic L., Matovic M., Bobic S., Novakovic T. Cosovic V., Mijucic J., Milovic Kovacevic M. Kancerološka nedelja (61; 2024; Beograd). Zbornik apstrakata 61.Kancerološka nedelja i 37. simpozijum medicinskih sestara-tehničara onkoloških institucija Republike Srbije.

· Ribociclib-induced phototoxicity – the era of new drugs and new toxicities. Simonida Bobic, Bjana Poparic-Bandjur, Milana Matovic, Lidija Pavlovic, Marijana Milovic-Kovacevic. Serbian archives of medicine. 2024 Volume 152, Issue 11-12, Pages: 618-622. https://doi.org/10.2298/SARH240925092B

· Tolerability of olaparib in patients with BRCA1/2 mutated platinum sensitive recurrent high grade serous ovarian cancer receiving olaparib maintenance monotherapy – a single institution experience. Lidija Pavlovic, Simonida Bobic, Andjela Karaferic, Marijana Milovic Kovacevic, Ljiljana Stamatovic. Lib Oncol.2021: 49(Suppl2): 35-71, P27.

· Pathological complete response rates with dual HER2 blockade added to neodjuvant chemotherapy in breast cancer:a single institution experience. Simonida Bobic, Lidija Pavlovic, Andjela Karaferic, Marijana Milovic Kovacevic, Ljiljana Stamatovic. Lib Oncol.2021: 49(Suppl2): 35-71, P21.

· Marija Mojić, Nataša Radulović, Simonida Bobić, Sandra Radenković, Aránzazu Cruz-Adalia, Ivana Stojanović. Innate lymphoid cells: Dual roles and therapeutic opportunities in breast cancer,. Immunology Letters, Volume 276, 2025, 107051, ISSN 0165-2478, https://doi.org/10.1016/j.imlet.2025.107051.